After the capital increase, the shareholding structure of Tianshan Pharmaceutical is as follows: China Pharmaceutical holds 565,438+0% equity of Tianshan Pharmaceutical, Xinjiang State-owned Assets Investment Management Co., Ltd. holds 23.73% equity of Tianshan Pharmaceutical, Japan Alpers Pharmaceutical Industry Co., Ltd. holds 23.265,438+0% equity of Tianshan Pharmaceutical, and Japan Longtai Trading Co., Ltd. holds 2.06% equity of Tianshan Pharmaceutical.